WHO Expert Committee on Drug Dependence : twenty-third report, meeting held in Geneva from 22 to 28 April 1986
Material type:
TextSeries: World Health Organization technical report series ; no. 741Publication details: Geneva : World Health Organization, 1987Description: 64 Pages; 20 cmISBN: - 9241207418
- 100 SD:610.621 WHO.Tr.741
| Item type | Current library | Call number | Status | Date due | Barcode | Item holds | |
|---|---|---|---|---|---|---|---|
| Reports | ISI Library, Kolkata Reports & Records Collection | 100 SD:610.621 WHO.Tr.741 (Browse shelf(Opens below)) | Available | C21577 |
Browsing ISI Library, Kolkata shelves, Shelving location: Reports & Records Collection Close shelf browser (Hides shelf browser)
|
|
|
|
|
|
|
||
| 100 SD:610.621 WHO.Tr.739 Epidemiology and control of African trypanosomiasis : report of a WHO expert committee, meeting held in Geneva from 16 to 23 October 1985 | 100 SD:610.621 WHO.TR.74 Expert Committee on Plague : second report | 100 SD:610.621 WHO.Tr.740 Joint FAO/WHO Expert Committee on Brucellosis : sixth report, meeting held in Geneva from 12 to 19 November 1985 | 100 SD:610.621 WHO.Tr.741 WHO Expert Committee on Drug Dependence : twenty-third report, meeting held in Geneva from 22 to 28 April 1986 | 100 SD:610.621 Who.Tr.742 Technology for water supply and sanitation in developing countries : report of a WHO study group [meeting held in Geneva from 14 to 19 April 1986] | 100 SD:610.621 WHO.TR.743 The biology of malaria parasites/ | 100 SD:610.621 WHO.TR (744) Hospitals and health for all/ |
Introduction -- 1. General Considerations -- 2. Methods used in assessing the thirty-one barbiturates -- 3. assessment of individual substances -- 4. Recommendations
Assesses data on 31 barbiturates in order to determine which of these substances should be recommended for international control. Barbiturates are classified in three main groups: ultra-short-acting barbiturates used as intravenous anaesthetics or for the induction of anaesthesia, the intermediate-acting barbiturates used mainly as hypnotics and daytime sedatives, and other longer-acting substances used in the management of epilepsy. Five of the 31 substances are recommended for placement in Schedule III or IV. A concluding section, devoted to recommendations for improving review procedures, discusses the problems caused by the difficulty of obtaining phenobarbital in many developing countries, especially in view of the effectiveness of this Schedule IV substance in the treatment of epilepsy.
There are no comments on this title.
